S. Gouy

发表

Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners

C. Haie-meder, Cyrus Chargari, Fanny Orlhac, 2017, Oncotarget.

Prognosis of Patients Who Relapse after Fertility-Sparing Surgery in Epithelial Ovarian Cancer

J. Schilder, P. Morice, C. Uzan, 2008, Annals of Surgical Oncology.

Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study.

I. Ray-Coquard, F. Goldwasser, O. Trédan, 2016, Oncology letters.

3D-conformal Accelerated Partial Breast Irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity

A. Dunant, H. Marsiglia, M. Spielmann, 2009, Radiation oncology.

Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer.

C. Pomel, S. Gouy, G. Ferron, 2016, Gynecologic oncology.

Surgical procedures and morbidities of diaphragmatic surgery in patients undergoing initial or interval debulking surgery for advanced-stage ovarian cancer.

C. Haie-meder, P. Morice, C. Uzan, 2010, Journal of the American College of Surgeons.

Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases.

R. Rouzier, P. Morice, C. Pomel, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours

C. Genestie, A. Dunant, J. Scoazec, 2019, British Journal of Cancer.

Sentinel Lymph Node in Endometrial Cancer: A Review

C. Haie-meder, P. Morice, C. Uzan, 2013, Current Oncology Reports.

Mucinous Ovarian Carcinoma.

A. Leary, P. Morice, S. Gouy, 2019, New England Journal of Medicine.

Correlation between [18f]fluorodeoxyglucose positron-emission tomography scan and histology of pelvic nodes in early-stage cervical cancer.

C. Haie-meder, M. Schlumberger, P. Morice, 2010, Anticancer Research.

Single-port endoscopic mesocolic and mesorectal excision using an extraperitoneal approach

S. Gouy, F. Dumont, D. Labbé, 2016, Surgical Endoscopy.

Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy

F. Bertucci, D. Birnbaum, P. Colombo, 2022, Journal of personalized medicine.

Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.

C. Genestie, R. Rouzier, F. Guyon, 2019, European journal of cancer.

Advanced microRNA-based cancer diagnostics using amplified time-gated FRET

J. Haybaeck, Michael DuBow, C. Uzan, 2018, Chemical science.

Cancer surgery during the COVID‐19 pandemic: The experience of a comprehensive cancer center performing preoperative screening by RT‐PCR and chest CT scan

T. de Baère, C. Balleyguier, P. Gorphe, 2021, Journal of surgical oncology.

Current Standards in the Management of Early and Locally Advanced Cervical Cancer: Update on the Benefit of Neoadjuvant/Adjuvant Strategies

C. Genestie, P. Morice, Yuedan Zhou, 2022, Cancers.

Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence.

E. Darai, P. Morice, C. Uzan, 2012, The Lancet. Oncology.

Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments.

E. Darai, P. Morice, C. Uzan, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.

E. Darai, P. Morice, C. Uzan, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of oxaliplatin-based hyperthermic intraperitoneal chemotherapy in recurrent ovarian granulosa cell tumors.

P. Morice, C. Uzan, S. Gouy, 2013, European journal of obstetrics, gynecology, and reproductive biology.

Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours.

E. Darai, R. Fauvet, P. Morice, 2013, Human reproduction.

The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.

D. Berton, F. Guyon, N. Radosevic-Robin, 2020, Gynecologic oncology.

Gynaecological cancers in pregnancy

C. Haie-meder, C. Verschraegen, P. Morice, 2012, The Lancet.

Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging.

C. Haie-meder, P. Morice, C. Uzan, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Para-Aortic Involvement and Interest of Para-Aortic Lymphadenectomy after Chemoradiation Therapy in Patients with Stage IB2 and II Cervical Carcinoma Radiologically Confined to the Pelvic Cavity

C. Haie-meder, P. Morice, C. Uzan, 2007, Annals of Surgical Oncology.

Transitory Stoma at the Time of Complete Cytoreductive Surgery Affects Survival for Patients with Advanced-stage Ovarian Cancer.

Cyrus Chargari, C. Genestie, P. Morice, 2018, Anticancer research.

Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian Cancer

E. Darai, F. Guyon, C. Ngô, 2016, Annals of Surgical Oncology.

Correlation Between Macroscopic and Microscopic Diseases on Splenectomies Performed in the Surgical Management of Ovarian Cancer

C. Uzan, S. Gouy, P. Duvillard, 2010, International Journal of Gynecologic Cancer.

Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France

V. Vinh-Hung, P. Morice, S. Gouy, 2022, Cancers.

Increasing global accessibility to high-level treatments for cervical cancers.

F. Bray, A. Leary, S. Gouy, 2021, Gynecologic oncology.

Outcome of Patients With Incomplete Resection After Surgery for Stage IB2/II Cervical Carcinoma With Chemoradiation Therapy

C. Haie-meder, C. Balleyguier, P. Morice, 2010, International Journal of Gynecologic Cancer.

Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy

C. Haie-meder, C. Balleyguier, P. Morice, 2008, Cancer.

Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer

C. Genestie, J. Adam, A. Leary, 2018, Cancers.

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis

M. Rubin, O. Elemento, C. Genestie, 2015, Cells.

Brachytherapy: An overview for clinicians

C. Haie-meder, I. Dumas, Cyrus Chargari, 2019, CA: a cancer journal for clinicians.

Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer.

P. Morice, C. Uzan, S. Gouy, 2012, Anticancer research.

Abstract P4-14-12: Evaluation of the effect of pasireotide LAR administration in the lymphocele prevention after mastectomy with axillary lymph node dissection for breast cancer: results of a phase 2 randomized study.

R. Rouzier, C. Mazouni, C. Uzan, 2012 .

Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape.

C. Genestie, A. Leary, P. Morice, 2020, Gynecologic oncology.

Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature.

Cyrus Chargari, P. Morice, S. Gouy, 2016, Fertility and sterility.

Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review.

Cyrus Chargari, A. Leary, P. Morice, 2016, The Lancet. Oncology.

Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.

C. Pomel, S. Gouy, O. Glehen, 2014, Journal of visceral surgery.

Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.

S. Msika, F. Guyon, E. Decullier, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Lymphocele and ovarian cancer: risk factors and impact on survival.

P. Morice, C. Uzan, S. Gouy, 2012, The oncologist.

[The age of the patient over 70 is a contraindication to perform para-aortic lymphadenectomy for ovarian cancer].

P. Morice, C. Uzan, S. Gouy, 2012, Gynecologie, obstetrique & fertilite.

Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.

P. Morice, C. Uzan, S. Gouy, 2012, European Journal of Surgical Oncology.

Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease.

P. Morice, C. Uzan, S. Gouy, 2009, European journal of obstetrics, gynecology, and reproductive biology.

Nodal-staging surgery for locally advanced cervical cancer in the era of PET.

C. Haie-meder, P. Morice, C. Uzan, 2012, The Lancet. Oncology.

Preoperative image-guided brachytherapy in early stage cervical cancers.

C. Haie-meder, I. Dumas, E. Deutsch, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy for locally advanced cervical cancer: assessment after 52 consecutive patients

P. Morice, C. Uzan, S. Gouy, 2013, Surgical Endoscopy.

A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer.

C. Genestie, A. Leary, P. Morice, 2020, Gynecologic oncology.

[Recent data in cervical cancer: Radiation oncologist's perspective].

C. Haie-meder, S. Gouy, C. Chargari, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.

P. Morice, C. Uzan, E. Daraï, 2013, Human reproduction update.

Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.

C. Haie-meder, P. Morice, C. Uzan, 2011, The oncologist.

Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.

P. Morice, C. Uzan, S. Gouy, 2009, The oncologist.

Results After Conservative Treatment of Serous Borderline Tumors of the Ovary with a Micropapillary Pattern

P. Morice, C. Uzan, S. Gouy, 2008, Annals of Surgical Oncology.

Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.

C. Genestie, A. Leary, M. Devouassoux‐Shisheboran, 2018, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

International study of primary mucinous ovarian carcinomas managed at tertiary medical centers

A. Iasonos, A. Leary, P. Morice, 2015 .

Factors associated with altered long-term well-being after prophylactic salpingo-oophorectomy among women at increased hereditary risk for breast and ovarian cancer.

S. Dauchy, A. Dunant, P. Morice, 2011, The oncologist.

Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies

F. Guyon, P. Rouanet, S. Gouy, 2019, International Journal of Gynecological Cancer.

Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study

F. Guyon, P. Colombo, P. Rouanet, 2018, Annals of Surgical Oncology.

Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External Radiotherapy

C. Haie-meder, C. Genestie, E. Deutsch, 2020, Journal of clinical medicine.

Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort.

R. Rouzier, P. Colombo, I. Ray-Coquard, 2022, Gynecologic oncology.

Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.

C. Haie-meder, I. Dumas, P. Morice, 2018, Gynecologic oncology.

Locally advanced cervical cancer: Is it relevant to report image-guided adaptive brachytherapy using point A dose?

C. Haie-meder, I. Dumas, Cyrus Chargari, 2017, Brachytherapy.

Management and prognosis of endometrioid borderline tumors of the ovary.

E. Darai, P. Morice, C. Uzan, 2012, Surgical oncology.

Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery.

C. Genestie, A. Leary, P. Morice, 2018, Anticancer research.

Results After Conservative Surgery of Stage II/III Serous Borderline Ovarian Tumors

C. Genestie, A. Leary, P. Morice, 2020, Annals of Surgical Oncology.

Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors.

C. Genestie, A. Leary, P. Morice, 2020, Gynecologic oncology.

Outcome of Patients With Advanced-Stage Borderline Ovarian Tumors After a First Peritoneal Noninvasive Recurrence: Impact on Further Management

A. Leary, P. Morice, C. Uzan, 2015, International Journal of Gynecologic Cancer.

How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary.

P. Morice, C. Uzan, S. Gouy, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary.

P. Morice, C. Uzan, S. Gouy, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Secondary Surgery in Patients With Serous Low Malignant Potential Ovarian Tumors With Peritoneal Implants

P. Morice, C. Uzan, S. Gouy, 2009, International Journal of Gynecologic Cancer.

Feasibility of ovarian cryopreservation in borderline ovarian tumours.

C. Genestie, P. Morice, C. Uzan, 2008, Human reproduction.

Malnutrition in Patients With Cancer: Comparison of Perceptions by Patients, Relatives, and Physicians—Results of the NutriCancer2012 Study

F. Goldwasser, X. Hébuterne, S. Gouy, 2017, JPEN. Journal of parenteral and enteral nutrition.

Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.

A. Leary, P. Morice, C. Uzan, 2014, Gynecologic oncology.

Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary.

P. Morice, C. Uzan, S. Gouy, 2010, Fertility and sterility.

Gynaecologic cancer surgery and preservation of fertility.

P. Morice, S. Gouy, E. Bentivegna, 2018, Journal of visceral surgery.

Fertility-sparing surgery in epithelial ovarian cancer: a systematic review of oncological issues.

A. Leary, N. Colombo, P. Morice, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients.

H. Kajiyama, N. Colombo, P. Morice, 2015, Fertility and sterility.

Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.

C. Haie-meder, C. Genestie, S. Culine, 2016, Gynecologic oncology.

The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy.

R. Rouzier, D. Elias, C. Pomel, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prognostic value of lymph node involvement in ovarian serous borderline tumors.

P. Morice, C. Uzan, S. Gouy, 2011, American journal of obstetrics and gynecology.

[Is radical surgery (or parametrectomy) needed in all surgical procedure for early stage cervical cancer?].

C. Haie-meder, P. Morice, C. Uzan, 2009, Gynecologie, obstetrique & fertilite.

Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging.

C. Haie-meder, C. Balleyguier, P. Morice, 2013, Clinical imaging.

Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma).

C. Haie-meder, P. Morice, C. Uzan, 2011, Human reproduction.

Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation.

C. Genestie, T. Leblanc, P. Touraine, 2019, Human reproduction.

Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, foll

F. Guyon, I. Ray-Coquard, A. Leary, 2019, Journal of gynecology obstetrics and human reproduction.

Oncofertility Applied to Epithelial Ovarian Cancer

P. Morice, C. Uzan, E. Daraï, 2017 .

Fertility-sparing surgery in epithelial ovarian cancer.

P. Morice, C. Uzan, S. Gouy, 2016, Future oncology.

Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review

I. Dumas, R. Sun, P. Morice, 2021, Cancers.

Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.

Cyrus Chargari, C. Genestie, A. Leary, 2018, The oncologist.

Gliomatosis Peritonei: A Particular Entity With Specific Outcomes Within the Growing Teratoma Syndrome

C. Genestie, P. Morice, C. Uzan, 2015, International Journal of Gynecologic Cancer.

Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 Cases

C. Genestie, C. Balleyguier, A. Leary, 2015, Annals of Surgical Oncology.

Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study

I. Fournier, F. Guyon, C. Pomel, 2023, Cancers.

Combined modality including novel sensitizers in gynecological cancers

A. Leary, Yuedan Zhou, S. Gouy, 2022, International Journal of Gynecological Cancer.

Laparoscopic Radical Hysterectomy after Preoperative Brachytherapy for Stage IB1 Cervical Cancer: Feasibility, Results, and Surgical Implications in a Large Bicentric Study of 162 Consecutive Cases

C. Haie-meder, P. Morice, C. Uzan, 2013, Annals of Surgical Oncology.

Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.

C. Haie-meder, P. Morice, C. Uzan, 2010, The oncologist.

Cancer de l’endomètre

S. Gouy, P. Pautier, R. Mazeron, 2011 .

Malignancies in Pregnancy 1 Gynaecological cancers in pregnancy

C. Haie-meder, C. Verschraegen, P. Morice, 2012 .

[The molecular biology of epithelial ovarian cancer].

C. Balleyguier, A. Leary, P. Morice, 2012, Bulletin du cancer.

Evaluation of adjuvant vaginal vault brachytherapy in early stage cervical cancer patients.

C. Haie-meder, C. Genestie, A. Leary, 2020, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Impact of the LACC study. A SFOG survey].

F. Guyon, S. Gouy, T. Gauthier, 2020, Bulletin du cancer.

FDG-PET/CT and Para-Aortic Staging in Endometrial Cancer. A French Multicentric Study

F. Guyon, J. Monteil, S. Gouy, 2021, Journal of clinical medicine.

Oncologic results of fertility sparing surgery of cervical cancer: An updated systematic review.

C. Genestie, P. Pautier, S. Gouy, 2022, Gynecologic oncology.

Lymphadenectomy for pregnant women with stage I cervical cancer – Authors' reply

P. Morice, C. Uzan, S. Gouy, 2012, The Lancet.

Prognostic impact of vitamin B6 metabolism in lung cancer.

E. Barillot, I. Wistuba, L. Zitvogel, 2012, Cell reports.

Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?

P. Morice, S. Gouy, D. Querleu, 2015, International Journal of Gynecologic Cancer.

Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area.

C. Haie-meder, P. Morice, C. Uzan, 2011, The oncologist.

Prognostic Factors of a Large Retrospective Series of Mucinous Borderline Tumors of the Ovary (Excluding Peritoneal Pseudomyxoma)

C. Haie-meder, P. Morice, C. Uzan, 2010, Annals of Surgical Oncology.

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)

C. Genestie, J. Adam, A. Dunant, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Bilateral postoperative brachial plexus palsy and longlasting surgery.

J. Bourgain, C. Motamed, S. Gouy, 2011, European journal of anaesthesiology.

Management of Endometrial Cancer: French Society of Onco-Gynecology‘s Evaluation through a Delphi Survey

C. Genestie, F. Guyon, C. Uzan, 2022, Journal of clinical medicine.

Implementation of image-guided brachytherapy as part of non-surgical treatment in inoperable endometrial cancer patients.

C. Haie-meder, N. Magné, A. Leary, 2020, Gynecologic oncology.

Neutrophilia in locally advanced cervical cancer: A novel biomarker for image-guided adaptive brachytherapy?

C. Haie-meder, Cyrus Chargari, P. Morice, 2016, Oncotarget.

Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy

C. Haie-meder, Cyrus Chargari, C. Genestie, 2016, Clinical & Experimental Metastasis.

Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers

C. Genestie, J. Scoazec, A. Leary, 2020, Virchows Archiv.

Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors

C. Genestie, I. Treilleux, I. Ray-Coquard, 2020, The American journal of surgical pathology.

Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours

C. Genestie, A. Dunant, J. Scoazec, 2019, British Journal of Cancer.

Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival

G. Le Teuff, P. Morice, C. Uzan, 2015, Oncotarget.

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae

C. Haie-meder, I. Dumas, Cyrus Chargari, 2018, Oncotarget.

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer

C. Genestie, A. Dunant, A. Leary, 2020, Cancer Immunology, Immunotherapy.

Isolated pelvic perfusion in irradiated unresectable recurrence of pelvic tumor: preliminary outcome and ongoing study.

S. Bonvalot, T. de Baère, C. Uzan, 2014, Journal of visceral surgery.

Metabolic features of cancer cells impact immunosurveillance

C. Genestie, G. Kroemer, J. Adam, 2021, Journal for ImmunoTherapy of Cancer.

[Malignant melanoma of the vagina: pejorative location].

C. Robert, P. Morice, C. Uzan, 2012, Gynecologie, obstetrique & fertilite.

[Intrathoracic localisation of desmoid tumours: a familial case of isolated desmoid tumours and current published data].

S. Gouy, L. Arnould, N. Cheynel, 2006, Annales de chirurgie.

Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma.

C. Haie-meder, Cyrus Chargari, P. Morice, 2017, Brachytherapy.

Malnutrition in Patients With Cancer: Comparison of Perceptions by Patients, Relatives, and Physicians-Results of the NutriCancer2012 Study.

F. Goldwasser, X. Hébuterne, S. Gouy, 2018, JPEN. Journal of parenteral and enteral nutrition.

Prise en charge des lésions urétérales iatrogènes Management of ureteral injuries

S. Gouy, N. Cheynel, B. Kretz, 2005 .

Interaction between the Number of Chemotherapy Cycles and Brachytherapy Dose/Volume Parameters in Locally Advanced Cervical Cancer Patients

C. Haie-meder, I. Dumas, A. Schernberg, 2020, Journal of clinical medicine.

Extra-peritoneal laparoscopic para-aortic lymphadenectomy for staging of uterine cervix carcinoma.

S. Gouy, M. Neveu, E. Bentivegna, 2017, Journal of visceral surgery.

The role of surgery after chemoradiation therapy and brachytherapy for stage IB2/II cervical cancer.

C. Haie-meder, P. Morice, C. Uzan, 2007, Gynecologic oncology.

Image-guided adaptive brachytherapy in primary vaginal cancers: A monocentric experience.

C. Haie-meder, I. Dumas, Cyrus Chargari, 2018, Brachytherapy.

Analysis of a Continuous Series of 34 Young Patients With Early-Stage Cervical Cancer Selected for a Vaginal Radical Trachelectomy: Should “Staging” Conization Be Systematically Performed Before This Procedure?

C. Haie-meder, P. Morice, C. Uzan, 2012, International Journal of Gynecologic Cancer.

A new single-port approach to perform a transperitoneal step and an extraperitoneal para-aortic lymphadenectomy with a single incision.

P. Morice, C. Uzan, S. Gouy, 2012, Journal of the American College of Surgeons.

Single port laparoscopic extraperitoneal paraaortic lymphadenectomy in locally advanced cervical cancer

P. Morice, C. Uzan, S. Gouy, 2012 .

Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements

C. Genestie, A. Leary, P. Morice, 2022, Annals of Surgical Oncology.

[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)].

F. Guyon, I. Ray-Coquard, A. Leary, 2019, Gynecologie, obstetrique, fertilite & senologie.

Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management

C. Genestie, A. Leary, P. Morice, 2021, Annals of Surgical Oncology.

Brenner Borderline Ovarian Tumor: A Case Series and Literature Review

C. Genestie, A. Leary, P. Morice, 2021, Annals of Surgical Oncology.

Management and Prognosis of Clear Cell Borderline Ovarian Tumor

E. Darai, P. Morice, C. Uzan, 2012, International Journal of Gynecologic Cancer.

Fertility-Sparing Strategy in Ovarian Tumors

P. Morice, S. Gouy, A. Maulard, 2022, Female and Male Fertility Preservation.

Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern

P. Morice, C. Uzan, S. Gouy, 2009, BJOG : an international journal of obstetrics and gynaecology.

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.

F. Guyon, I. Ray-Coquard, A. Leary, 2019, European journal of obstetrics, gynecology, and reproductive biology.

Management and Prognosis of Borderline Ovarian Brenner Tumors

E. Darai, P. Morice, C. Uzan, 2012, International Journal of Gynecologic Cancer.

Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registry.

C. Genestie, A. Dunant, E. Lanoy, 2020, Gynecologic oncology.

Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patients.

C. Genestie, D. Pezet, P. Morice, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Immediate Reconstruction After Neoadjuvant Chemotherapy: Effect on Adjuvant Treatment Starting and Survival

R. Rouzier, D. Atallah, S. Gouy, 2005, Annals of Surgical Oncology.

Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types

C. Genestie, A. Leary, P. Morice, 2017, Gynecologic oncology reports.

Primary Psammocarcinoma of the Ovary or Peritoneum

P. Morice, C. Uzan, S. Gouy, 2009, International Journal of Gynecologic Cancer.

Brachytherapy for the Conservative Treatment of Female Peri-Urethral Carcinoma

C. Haie-meder, R. Sun, P. Morice, 2022, Cancers.

Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center.

C. Haie-meder, C. Genestie, A. Bertaut, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Tumor Shrinkage During Chemoradiation in Locally Advanced Cervical Cancer Patients: Prognostic Significance, and Impact for Image-Guided Adaptive Brachytherapy.

C. Haie-meder, Cyrus Chargari, A. Schernberg, 2018, International journal of radiation oncology, biology, physics.

[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

C. Genestie, R. Rouzier, F. Guyon, 2018, Bulletin du cancer.

False negative rate at 18F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology

C. Genestie, A. Leary, P. Morice, 2021, BMC cancer.

Reply to M.S. Rajagopalan et al and P.G. Rose.

P. Morice, S. Gouy, D. Querleu, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Laparoscopic para-aortic lymphadenectomy in advanced cervical cancer: morbidity and impact on therapy].

C. Haie-meder, P. Morice, C. Uzan, 2012, Gynecologie, obstetrique & fertilite.

Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy: about fourteen consecutive cases.

Aminata Kane, Jennifer Gilmore, P. Morice, 2011, Gynecologic oncology.

[Survival and prognostic factors after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer].

C. Haie-meder, P. Morice, C. Uzan, 2011, Gynecologie, obstetrique & fertilite.

[Para-aortic lymphadenectomy in advanced-stage cervical cancer: standard procedure in 2010?].

C. Haie-meder, P. Morice, C. Uzan, 2010, Gynecologie, obstetrique & fertilite.

Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment.

C. Haie-meder, I. Dumas, Cyrus Chargari, 2017, The oncologist.

Total Reference Air Kerma is Associated with Late Bowel Morbidity in Locally Advanced Cervical Cancer Patients Treated with Image-Guided Adaptive Brachytherapy

C. Haie-meder, I. Dumas, P. Morice, 2019, Journal of clinical medicine.

Sentinel lymph node biopsy in two Burgundy districts: prospective multicentric study on 528 breast cancers during the year 2005

S. Gouy, S. Causeret, A. Berriolo-Riedinger, 2010, Archives of Gynecology and Obstetrics.

Cervical Cancer and Fertility-Sparing Treatment

C. Genestie, A. Leary, P. Morice, 2021, Journal of clinical medicine.

Neoadjuvant chemotherapy in fertility-sparing management of FIGO 2018 stage IB2 cervical cancer

C. Genestie, P. Morice, S. Gouy, 2022, International Journal of Gynecological Cancer.

Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy.

C. Haie-meder, C. Genestie, A. Leary, 2020, Gynecologic oncology.

Laparoendoscopic Single-site Surgery (LESS) for Prophylactic Salpingo-oophorectomy Improves Cosmetic Satisfaction Compared to Standard Laparoscopy.

S. Dauchy, C. Charles, P. Morice, 2015, Anticancer Research.

Impact of sentinel node biopsy on long-term quality of life in breast cancer patients

C. Coutant, P. Arveux, F. Bonnetain, 2013, British Journal of Cancer.

Adjuvant chemotherapy in stage I ovarian germ cell tumors: should indications and treatment modalities be different in young girls and adults?

A. Leary, P. Morice, C. Uzan, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multimodal Management of Locally Advanced Neuroendocrine Cervical Carcinoma: A Single Institution Experience

C. Haie-meder, Cyrus Chargari, C. Genestie, 2018, International Journal of Gynecologic Cancer.

Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial.

R. Rouzier, P. Colombo, E. Kalbacher, 2017, European journal of cancer.

Accuracy and Reproducibility of the Peritoneal Cancer Index in Advanced Ovarian Cancer During Laparoscopy and Laparotomy

P. Morice, C. Uzan, S. Gouy, 2013, International Journal of Gynecologic Cancer.

[French recommendations for endometrial cancer 2010: clinical use and questions still debated].

C. Haie-meder, P. Morice, C. Uzan, 2012, Bulletin du cancer.

A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection.

P. Arveux, F. Bonnetain, S. Gouy, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Brachytherapy for pediatric patients at Gustave Roussy Cancer Campus: A model of international cooperation for highly specialized treatments.

C. Haie-meder, D. Orbach, S. Sarnacki, 2022, International journal of radiation oncology, biology, physics.

Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.

D. Berton, I. Ray-Coquard, A. Floquet, 2023, Gynecologic oncology.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian Cancer.

S. Msika, F. Guyon, E. Decullier, 2015, Anticancer research.

Feasibility of a video-based cognitive behavioral therapy for insomnia in French adult cancer outpatients: results from the Sleep-4-All-1 study

D. Planchard, S. Dauchy, G. Ninot, 2021, Supportive Care in Cancer.

Diffusion-weighted MRI in image-guided adaptive brachytherapy: Tumor delineation feasibility study and comparison with GEC-ESTRO guidelines.

C. Haie-meder, I. Dumas, Cyrus Chargari, 2017, Brachytherapy.

Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors.

C. Haie-meder, I. Dumas, Cyrus Chargari, 2017, Gynecologic oncology.

Should Pelvic and Para-aortic Lymphadenectomy Be Different Depending on Histological Subtype in Epithelial Ovarian Cancer?

P. Morice, C. Uzan, S. Gouy, 2007, Annals of Surgical Oncology.

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis

M. Rubin, O. Elemento, C. Genestie, 2020, Cells.

Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.

C. Genestie, A. Leary, P. Morice, 2018, The oncologist.

Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type

C. Genestie, A. Leary, P. Morice, 2018, International Journal of Gynecologic Cancer.

Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?

C. Genestie, A. Leary, P. Morice, 2017, Gynecologic Oncology Reports.

Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact.

C. Haie-meder, I. Dumas, C. Genestie, 2016, Radiotherapy and Oncology.

Results of conservative treatment of epithelial ovarian tumor.

P. Morice, C. Uzan, S. Gouy, 2009, Gynecologic oncology.

Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?

C. Genestie, A. Leary, P. Morice, 2019, AntiCancer Research.

[Postoperative morbidity after completion surgery following homogeneous chemoradiation therapy in locally advanced cervical cancer].

C. Haie-meder, P. Morice, C. Uzan, 2010, Journal de gynecologie, obstetrique et biologie de la reproduction.

P. Morice, C. Uzan, J. Lumbroso, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical management of cervical cancer

P. Morice, C. Uzan, S. Gouy, 2014 .

[Fertility preservation in cervical cancer, analysis of 30 years of practice and immersion in future developments.]

C. Genestie, C. Balleyguier, A. Leary, 2021, Gynecologie, obstetrique, fertilite & senologie.

Advanced microRNA-based cancer diagnostics using amplified time-gated FRET

J. Haybaeck, Michael DuBow, C. Uzan, 2018, Chemical science.

[Current post-surgical treatment strategies in first-line ovarian cancer].

C. Genestie, A. Leary, P. Morice, 2023, Bulletin du cancer.

Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence.

E. Darai, P. Morice, C. Uzan, 2012, The Lancet. Oncology.

Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment.

C. Haie-meder, I. Dumas, Cyrus Chargari, 2017, The oncologist.

Prognostic impact of vitamin B6 metabolism in lung cancer.

E. Barillot, I. Wistuba, L. Zitvogel, 2012, Cell reports.

Changes in DNA Damage Response Markers with Treatment in Advanced Ovarian Cancer

C. Genestie, J. Adam, A. Leary, 2020, Cancers.

Mucinous Ovarian Carcinoma.

A. Leary, P. Morice, S. Gouy, 2019, The New England journal of medicine.

[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

C. Genestie, F. Guyon, C. Rousset-Jablonski, 2018, Bulletin du cancer.

Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy

C. Haie-meder, C. Balleyguier, P. Morice, 2008, Cancer.

International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers

A. Iasonos, A. Leary, P. Morice, 2018, International Journal of Gynecologic Cancer.

Results of a prospective phase II national study: Prophylactic radical fimbriectomy (NCT01608074), in women with a documented high risk of breast/ovarian cancer—Final pathological results and outcomes.

F. Guyon, C. Pomel, D. Hudry, 2020 .

[Application in France of the 2021 European recommendations on endometrial cancer].

Cyrus Chargari, C. Genestie, F. Guyon, 2022, Bulletin du cancer.

Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid

S. Gouy, F. Blanc-Durand, A. Maulard, 2023, Molecular Cancer.

[The molecular biology of epithelial ovarian cancer].

C. Balleyguier, A. Leary, P. Morice, 2012, Bulletin du cancer.

Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers

L. Zitvogel, C. Radulescu, M. Rouanne, 2023, Journal of Experimental & Clinical Cancer Research.

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer

C. Genestie, S. Gouy, A. Oaknin, 2024, Journal for immunotherapy of cancer.